Exploring the oncogenic roles of T-box transcription factor TBX2 and its potential as a therapeutic targetBIOCHEMICAL SOCIETY TRANSACTIONSIF4.32025-02-060PRE
Binuclear palladacycles with ionisable and non-ionisable tethers as anticancer agentsJOURNAL OF INORGANIC BIOCHEMISTRYIF3.22024-08-011OAAI
Chromomycin A5, a marine-derived antibiotic, targets the oncogenic TBX2 in breast cancerMOLECULAR CANCER THERAPEUTICSIF5.52021-12-010PRE
Targeting the Oncogenic TBX2 Transcription Factor With ChromomycinsFRONTIERS IN CHEMISTRYIF4.22020-03-0310OAAI